Larimar Therapeutics, Inc. SEC filings LRMR
Larimar Therapeutics, Inc. has 696 filings in SEC EDGAR's recent list, going back to Aug 28, 2006. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Mar 19, 2026 | — |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Feb 25, 2026 | — |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| 424B5 | Prospectus supplement | Jul 29, 2025 | — |
| S-8 | Employee stock plan registration | Mar 24, 2025 | — |
| S-3 | Shelf registration | May 9, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| 424B5 | Prospectus supplement | Feb 14, 2024 | — |
| 424B5 | Prospectus supplement | Feb 13, 2024 | — |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| S-8 | Employee stock plan registration | Mar 14, 2023 | — |
| S-3 | Shelf registration | Nov 10, 2022 | — |
| 424B5 | Prospectus supplement | Sep 14, 2022 | — |
| S-8 | Employee stock plan registration | Oct 2, 2020 | — |
| S-3 | Shelf registration | Aug 14, 2020 | — |
| S-3 | Shelf registration | Jun 26, 2020 | — |
| S-8 | Employee stock plan registration | Jun 26, 2020 | — |
| S-8 | Employee stock plan registration | Mar 5, 2020 | — |
| S-8 | Employee stock plan registration | Nov 7, 2019 | — |
| S-8 | Employee stock plan registration | Mar 14, 2019 | — |
| 424B5 | Prospectus supplement | Nov 9, 2018 | — |
| S-3 | Shelf registration | Nov 9, 2018 | — |
| S-8 | Employee stock plan registration | Nov 9, 2018 | — |
| 424B5 | Prospectus supplement | Jun 28, 2018 | — |
| 424B5 | Prospectus supplement | Jun 27, 2018 | — |
| S-8 | Employee stock plan registration | Mar 9, 2018 | — |
| S-3 | Shelf registration | Aug 9, 2017 | — |
| S-8 | Employee stock plan registration | Mar 10, 2017 | — |
| S-8 | Employee stock plan registration | Mar 15, 2016 | — |
| S-8 | Employee stock plan registration | Jun 12, 2015 | — |
| 424B4 | Prospectus | Jan 23, 2015 | — |
| S-1MEF | Filing | Jan 22, 2015 | — |
| S-1/A | Amended registration statement | Jan 22, 2015 | — |
| S-1/A | Amended registration statement | Jan 16, 2015 | — |
| S-1 | Registration statement | Jan 12, 2015 | — |
| S-8 | Employee stock plan registration | Jun 19, 2014 | — |
| 424B4 | Prospectus | Jun 19, 2014 | — |
| S-1MEF | Filing | Jun 18, 2014 | — |
| S-1/A | Amended registration statement | Jun 16, 2014 | — |
| S-1/A | Amended registration statement | Jun 5, 2014 | — |
| S-1/A | Amended registration statement | Jun 2, 2014 | — |
| S-1/A | Amended registration statement | May 2, 2014 | — |
| S-1/A | Amended registration statement | Apr 28, 2014 | — |
| S-1 | Registration statement | Apr 18, 2014 | — |
Showing 46 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LRMR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bala Cynwyd, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1374690
- Former names
- ZAFGEN, INC. (until May 19, 2020); ZAFGEN INC (until Nov 3, 2008)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.